What is WHO in myelodysplastic syndromes?

被引:0
|
作者
Bennett, J. M. [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Dept Med, James P Wilmot Canc Ctr, Rochester, MN USA
关键词
D O I
10.1016/S0145-2126(07)70003-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1 / S1
页数:1
相关论文
共 50 条
  • [1] What is 'WHO' in the myelodysplastic syndromes?
    Bennett, John M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 52 - 53
  • [2] The WHO classification of the myelodysplastic syndromes
    Bain, B
    EXPERIMENTAL ONCOLOGY, 2004, 26 (03) : 166 - 169
  • [3] Reclassifying myelodysplastic syndromes: what's where in the new WHO and why
    Arber, Daniel A.
    Hasserjian, Robert P.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 294 - 298
  • [4] Problematic WHO reclassification of myelodysplastic syndromes
    Greenberg, P
    Anderson, J
    de Witte, T
    Estey, E
    Fenaux, P
    Gupta, P
    Hamblin, T
    Hellstrom-Lindberg, E
    List, A
    Mufti, G
    Neuwirtova, R
    Ohyashiki, K
    Oscier, D
    Sanz, G
    Sanz, M
    Willman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3447 - 3449
  • [5] Luspatercept in Myelodysplastic Syndromes Who and When?
    Komrokji, Rami S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (02) : 393 - +
  • [6] Who is WHO in myelodysplastic syndromes? Clinical implications of the WHO classification
    Komrokji R.S.
    Bennett J.M.
    Current Hematologic Malignancy Reports, 2006, 1 (1) : 9 - 15
  • [7] What's new in myelodysplastic syndromes?
    Della Porta, M. G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S2 - S3
  • [8] WHAT IS INEFFECTIVE ERYTHROPOIESIS IN MYELODYSPLASTIC SYNDROMES
    BOWEN, D
    LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) : 243 - 247
  • [9] Problematic WHO reclassification of myelodysplastic syndromes - Reply
    Head, D
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3451 - 3452
  • [10] What constitutes meaningful improvement in myelodysplastic syndromes?
    Chandhok, Namrata S.
    Sekeres, Mikkael A.
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2528 - 2535